What is the equity of AstraZeneca this year?
AstraZeneca has equity of 39.14 B USD this year.
AstraZeneca Equity 2024
AstraZeneca Equity
39.14 B USD
Ticker
AZN.L
ISIN
GB0009895292
WKN
886455
In 2024, AstraZeneca's equity was 39.14 B USD, a 5.69% increase from the 37.04 B USD equity in the previous year.
AstraZeneca Aktienanalyse
What does AstraZeneca do?
AstraZeneca PLC is a globally operating pharmaceutical company with its headquarters in England. The company was founded in 1999 through the merger of the Swedish company Astra AB and the British Zeneca Group PLC. Today, AstraZeneca employs more than 70,000 people and operates in over 100 countries. AstraZeneca specializes in the development, manufacturing, and marketing of pharmaceutical products. The company focuses primarily on oncology, cardiovascular and metabolic diseases, respiratory diseases, and autoimmune diseases. AstraZeneca is divided into various business segments. The oncology segment is a major focus of the company. Here, medications for various types of cancer are developed and manufactured. One particularly well-known product is the breast cancer medication Tamoxifen. In the cardiovascular and metabolic diseases segment, AstraZeneca offers various medications for heart and circulatory diseases as well as diabetes. One of the most well-known medications is Crestor, which is used to lower cholesterol levels. Another important area for AstraZeneca is respiratory diseases. Medications for the treatment of asthma and chronic obstructive pulmonary disease (COPD) are developed and manufactured here. The medication Pulmicort is particularly well-known among asthma patients. Finally, AstraZeneca is also active in the field of autoimmune diseases. Medications against lupus erythematosus and rheumatoid arthritis are developed and manufactured here. AstraZeneca strives to improve healthcare worldwide through research and development of new medications. The company works closely with universities and research institutions and invests billions of dollars annually in research and development. AstraZeneca also pursues a sustainable business strategy and emphasizes acting environmentally and socially responsibly. The company is committed to reducing CO2 emissions and minimizing waste production. Over the years, AstraZeneca has received numerous awards and prizes, including the Sunday Times Innovation Award of the Decade, the Fierce Biotech Award for the medication Tagrisso, and the Prix Galien USA Award for Crestor. AstraZeneca aims to develop innovative medications that improve the lives of patients and advance healthcare worldwide. The company believes in a sustainable business strategy and actively promotes environmental and social responsibility. AstraZeneca will remain an important player in the global pharmaceutical industry in the future. AstraZeneca ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing AstraZeneca's Equity
AstraZeneca's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding AstraZeneca's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating AstraZeneca's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
AstraZeneca's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in AstraZeneca’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about AstraZeneca stock
What was the equity of AstraZeneca compared to the previous year?
The equity of AstraZeneca has increased/decreased by 5.69% increased compared to the previous year.
What impact does a high equity have on investors of AstraZeneca?
A high equity is advantageous for investors of AstraZeneca as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of AstraZeneca?
A low equity can be a risk for investors of AstraZeneca, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of AstraZeneca affect the company?
An increase in equity of AstraZeneca can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of AstraZeneca affect the company?
A reduction in equity of AstraZeneca can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of AstraZeneca?
Some factors that can affect the equity of AstraZeneca include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of AstraZeneca so important for investors?
The equity of AstraZeneca is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can AstraZeneca take to change the equity?
To change equity, AstraZeneca can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does AstraZeneca pay?
Over the past 12 months, AstraZeneca paid a dividend of 2.35 USD . This corresponds to a dividend yield of about 1.51 %. For the coming 12 months, AstraZeneca is expected to pay a dividend of 1.01 USD.
What is the dividend yield of AstraZeneca?
The current dividend yield of AstraZeneca is 1.51 %.
When does AstraZeneca pay dividends?
AstraZeneca pays a quarterly dividend. This is distributed in the months of March, September, March, September.
How secure is the dividend of AstraZeneca?
AstraZeneca paid dividends every year for the past 26 years.
What is the dividend of AstraZeneca?
For the upcoming 12 months, dividends amounting to 1.01 USD are expected. This corresponds to a dividend yield of 0.65 %.
In which sector is AstraZeneca located?
AstraZeneca is assigned to the 'Health' sector.
Wann musste ich die Aktien von AstraZeneca kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of AstraZeneca from 9/9/2024 amounting to 0.776 USD, you needed to have the stock in your portfolio before the ex-date on 8/8/2024.
When did AstraZeneca pay the last dividend?
The last dividend was paid out on 9/9/2024.
What was the dividend of AstraZeneca in the year 2023?
In the year 2023, AstraZeneca distributed 2.217 USD as dividends.
In which currency does AstraZeneca pay out the dividend?
The dividends of AstraZeneca are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The AstraZeneca stock can be added to a savings plan with the following providers: Scalable Capital and Consorsbank
Andere Kennzahlen von AstraZeneca
Our stock analysis for AstraZeneca Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AstraZeneca Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
